<XML><RECORDS><RECORD><REFERENCE_TYPE>3</REFERENCE_TYPE><REFNUM>9164</REFNUM><AUTHORS><AUTHOR>Harris,K.</AUTHOR><AUTHOR>Girolami,M.</AUTHOR><AUTHOR>Mischak,H.</AUTHOR></AUTHORS><YEAR>2009</YEAR><TITLE>Definition of Valid Proteomic Biomarkers: A Bayesian Solution</TITLE><PLACE_PUBLISHED>Pattern Recognition In Bioinformatics 2009</PLACE_PUBLISHED><PUBLISHER>Springer Verlag</PUBLISHER><LABEL>Harris:2009:9164</LABEL><KEYWORDS><KEYWORD>Proteomic biomarkers</KEYWORD></KEYWORDS<ABSTRACT>Clinical proteomics is suffering from high hopes generated by reports on apparent biomarkers, most of which could not be later substantiated via validation. This has brought into focus the need for improved methods of finding a panel of clearly defined biomarkers. To examine this problem, urinary proteome data was collected from healthy adult males and females, and analysed to find biomarkers that differentiated between genders. We believe that models that incorporate sparsity in terms of variables are desirable for biomarker selection, as proteomics data typically contains a huge number of variables (peptides) and few samples making the selection process potentially unstable. This suggests the application of a two-level hierarchical Bayesian probit regression model for variable selection which assumes a prior that favours sparseness. The classification performance of this method is shown to improve that of the Probabilistic K-Nearest Neighbour model.</ABSTRACT></RECORD></RECORDS></XML>